Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
2646 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-02-27 (fool.com)
AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript |
ABCL earnings call for the period ending December 31, 2024.
Read more
2025-02-21 (globallegalchronicle.com)
Stoke Therapeutics' Collaboration with BioGen – Global Legal Chronicle
Fenwick & West represented Stoke Therapeutics, Inc. in the transaction.Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's…
Read more
2025-02-18 (citeline.com)
Stoke Gets Runway, Biogen A Late-Stage Asset In Epilepsy Collaboration
Biogen will pay $165m up front for ex-North American rights to Stoke's Phase III-ready Dravet syndrome candidate, an antisense drug offering disease-modifying potential.
Read more
2025-02-18 (gazzettadisalerno.it)
Medicine, Life Science Exellence Show: the Digital Neuro Hub training project - Gazzetta di Salerno, the online newspaper of Salerno awarded
(Adnkronos) - The innovative training project of Digital Health 'Digital Neuro Hub', born from the partnership between Biogen Italy and the Italian company
Read more
2025-02-18 (tipranks.com)
Biogen, Stoke Therapeutics announce zorevunersen commercialization agreement - TipRanks.com
Biogen (BIIB) and Stoke Therapeutics (STOK) announced a collaboration for the development and commercialization of zorevunersen, a potential disease modifying medic...
Read more
2025-02-18 (statnews.com)
Biogen partners with Stoke Therapeutics to sell severe epilepsy drug
Today's biotech news includes Biogen partnering with Stoke Therapeutics, the medical ethics of abruptly canceling USAID trials, and more.
Read more
2025-02-12 (tradingview.com)
BIOGEN INC. SEC 10-K Report — News
Biogen Inc., a leading biopharmaceutical company specializing in neurological and rare disease treatments, has released its 2024 Form 10-K report. The report provides a comprehensive overview of the company's financial performance, business operations, strategic initiatives, and the challenges it f…
Read more
2025-01-31 (mmm-online.com)
Rx Rundown: Merck, Biogen, Pfizer and more - MM+M - Medical Marketing and Media
Check out this week’s medical marketing news, dealmaking and industry chatter.
Read more
2025-01-29 (thenewspaper.co.za)
Elite Riders Gear Up for the 2025 Momentum Medical Scheme Tankwa Trek
Kate Courtney|Candice Lill’s She Sends privateer super squad and Lukas Baum?Georg Egger’s ORBEA x Leatt x Speed Company headline Tankwa Trek.
Read more